Position in NVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$80,577,756
New position
Shares Held
2,192,592
first reported quarter
Ownership
0.050%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Defiance ETFs, LLC holds $12,612,629 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,554 | $4,262,774 | |
| 2 | JNJ |
Johnson & Johnson
|
10,189 | $2,587,700 | |
| 3 | ABBV |
AbbVie Inc.
|
7,506 | $1,888,809 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,312 | $1,325,092 | |
| 5 | AMGN |
Amgen Inc
|
2,282 | $826,357 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,089 | $642,944 | |
| 7 | PFE |
Pfizer Inc
|
23,994 | $577,775 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,698 | $501,178 |
All Filings in NVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $80,577,756 | 2,192,592 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||